Conavi Medical Corp. logo

Conavi Medical Corp. (YU1)

Market Closed
XSTU XSTU
30.42M Market Cap
- P/E Ratio
0% Div Yield
- Volume
- Eps
Previous Close
Day Range
0 0
Year Range
0 0
Want to track YU1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

YU1 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSTU (EUR).

YU1 Chart

Similar

1RC
Creo Medical Group plc
0.1
-5.41%
7ZT
Hamlet Biopharma AB (publ)
-
-
J8P
Cinclus Pharma Holding AB
-
-
SG0
Fibrobiologics Inc.
-
-
Precision Biosciences Inc.
-
-

Conavi Medical Corp. (YU1) FAQ

What is the stock price today?

The current price is €0.00.

On which exchange is it traded?

Conavi Medical Corp. is listed on XSTU.

What is its stock symbol?

The ticker symbol is YU1.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 30.42M.

Has Conavi Medical Corp. ever had a stock split?

No, there has never been a stock split.

Conavi Medical Corp. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Thomas Looby CEO
XSTU Exchange
- ISIN
Canada Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Conavi Medical Corp. is a pioneering company rooted in the heart of Toronto, Canada, specializing in the domain of medical imaging technologies with a primary focus on enhancing the accuracy and effectiveness of minimally invasive cardiovascular procedures. The organization is renowned for its innovative approach towards developing, manufacturing, and marketing advanced imaging solutions aimed at providing clearer, more precise images to guide clinicians during cardiovascular interventions. Their expertise and commitment to improving patient outcomes have positioned Conavi Medical Corp. as a leader in the medical imaging technology industry, particularly in the field of cardiovascular procedures.

Products and Services

  • Novasight Hybrid System

This highly advanced imaging system represents a significant breakthrough in the field of cardiovascular diagnostics and interventions. The Novasight Hybrid System is ingeniously designed to integrate two critical imaging modalities: intravascular ultrasound (IVUS) and optical coherence tomography (OCT). This unique combination allows for simultaneous and co-registered imaging capabilities, providing clinicians with an unparalleled view of coronary arteries. The system's dual-modality approach not only enhances the precision of diagnostic assessments but also significantly improves the efficacy and safety of minimally invasive cardiovascular procedures. By offering a comprehensive imaging solution, the Novasight Hybrid System underscores Conavi Medical Corp.’s commitment to advancing cardiac care and improving patient outcomes.

Contact Information

Address: 293 Lesmill Road
Phone: -